Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. Sustainability Profile
Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd., commonly referred to as Sinopep, is a leading player in the biopharmaceutical industry, headquartered in Jiangsu, China. Established in 2003, the company has made significant strides in the development and production of innovative biopharmaceutical products, focusing on areas such as peptide synthesis and drug formulation. Sinopep's core offerings include a range of high-quality peptides and biologics, distinguished by their advanced manufacturing processes and commitment to research and development. The company has positioned itself as a trusted partner in the global pharmaceutical market, catering to both domestic and international clients. With a strong emphasis on quality and innovation, Sinopep has achieved notable milestones, solidifying its reputation as a key contributor to the biopharmaceutical landscape. Its dedication to excellence continues to drive its growth and influence within the industry.
DitchCarbon Score
How does Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.'s score of 22 is lower than 76% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.'s reported carbon emissions
Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd., headquartered in China, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Furthermore, the company has not established any documented reduction targets or climate pledges, which suggests a lack of formal commitments to reducing its carbon footprint at this time. As there are no emissions data or reduction initiatives available, it is unclear how Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. aligns with industry standards for climate action. The absence of specific targets or commitments may reflect a broader trend within the biopharmaceutical sector, where companies are increasingly being called upon to disclose their environmental impact and set ambitious sustainability goals. In summary, Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. currently lacks publicly available emissions data and formal climate commitments, highlighting an area for potential improvement in transparency and environmental responsibility within the industry.
How Carbon Intensive is Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.'s Industry?
How Carbon Intensive is Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.'s Location?
Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
